Nomura Holdings’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Nomura Holdings’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-140,000	Closed	-$1.14M	–	3119
2014 Q2	$1.14M	Buy	+140,000	New	+$1.06M	﹤0.01%	1382

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nomura Holdings's SPPI Position: Q4 2021 in Review

Nomura Holdings sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2021, closing a stake of 10,400 shares — an estimated $23K sold.

Nomura Holdings first reported a position in SPPI in Q2 2013 and held it in 11 quarters. The position peaked at $539K in Q3 2013. 142 funds tracked by Wall St. Rank hold SPPI as of Q4 2021.

Nomura Holdings reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
Nomura Holdings sold 10,400 Spectrum Pharmaceuticals Inc shares in Q4 2021, an estimated $23K.
Nomura Holdings first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 11 quarters.
Nomura Holdings's Spectrum Pharmaceuticals Inc position peaked at $539K in Q3 2013.
142 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2021.

Based on Nomura Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.